Compare · CPUH vs TENK
CPUH vs TENK
Side-by-side comparison of Compute Health Acquisition Corp. (CPUH) and TenX Keane Acquisition (TENK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CPUH and TENK operate in Blank Checks (Finance), so they compete in similar markets.
- CPUH carries a market cap of $1.05B.
CPUH
Compute Health Acquisition Corp.
Compute Health Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Wilmington, Delaware.
Latest CPUH
- SEC Form 15-12G filed by Compute Health Acquisition Corp.
- SEC Form 4: Compute Health Sponsor Llc was granted 2,088,327 shares and returned 2,088,327 shares to the company (Amendment)
- SEC Form 4: Harsh Michael was granted 21,120 shares and returned 31,120 shares to the company, closing all direct ownership in the company
- SEC Form 4: Watanabe Gwendolyn A was granted 21,120 shares and returned 21,120 shares to the company
- SEC Form 25-NSE filed by Compute Health Acquisition Corp.
- Allurion Debuts as a Publicly Traded Company on the NYSE
- SEC Form DEFA14A filed by Compute Health Acquisition Corp.
- Compute Health Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Compute Health Acquisition Corp. Stockholders Approve Business Combination with Allurion
- SEC Form 425 filed by Compute Health Acquisition Corp.
Latest TENK
- Amendment: SEC Form SC 13D/A filed by TenX Keane Acquisition
- SEC Form 4 filed by Director Dutia Suren G
- SEC Form 4 filed by Director Holubiak Myron Z
- SEC Form 4 filed by Chief Medical Officer Czuczman Myron
- SEC Form 4 filed by Chief Executive Officer Mazur Leonard L
- SEC Form 4 filed by Chief Financial Officer Bartushak Jaime
- SEC Form 4 filed by Director Mcgrath Dennis M
- SEC Form 4 filed by Large owner Citius Pharmaceuticals, Inc.
- SEC Form 4 filed by Director Webb Carol
- SEC Form 3 filed by new insider Dutia Suren G